Company Search:
Advanced Search
Sponsored Links
Eli Lilly and Company Company Snapshot
Eli Lilly and Company operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eli Lilly and Company with three other companies in this sector in UNITED STATES : Bristol-Myers Squibb Company (2019 sales of $26.15 billion of which 30% was Prioritized Brands-Eliquis), Takeda Pharmaceutical Company Limited ($18.90 billion of which 97% was Pharmaceutical Business), and AstraZeneca PLC ($24.38 billion of which 100% was BioPharmaceuticals).

Sales Analysis. Eli Lilly and Company reported sales of $22.32 billion for the year ending December of 2019. This represents a decrease of 9.1% versus 2018, when the company's sales were $24.56 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Eli Lilly and Company
  Stock Performance Chart for Eli Lilly and Company
  Stock Data: Recent Stock Performance:
  Current Price (1/8/2021): 166.41
(Figures in U.S. Dollars)
1 Week -1.4%   13 Weeks 4.0%  
4 Weeks 6.1%   52 Weeks 20.6%  
Eli Lilly and Company Key Data:
  Ticker: LLY Country: United States
  Exchanges: NYSE FRA LON MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 22,319,500,000
(Year Ending Jan 2020).
Employees: 33,625
  Currency: U.S. Dollars Market Cap: 159,169,667,310
  Fiscal Yr Ends: December Shares Outstanding: 956,491,000
  Share Type: Common Closely Held Shares: 1,499,348
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.